Abstract��OBJECTIVE To explore ways and paths to strengthen team building of China's drug inspectors. METHODS By analyzing and summarizing the experience and enlightenment of the US FDA's drug inspector team, a series of research are launched considering current situation of drug inspectors, and problems in the China's drug inspector team building are analyzed in depth. RESULTS It is to provide approaches and methods for the construction of China's drug inspection team. CONCLUSION The construction of China's drug inspection team should combine both long-term and short-term considerations and solve problems step by step. In the long run, professionalism is the orientation. In the near future, before realization of professionalism, the construction of drug inspectors should focus on specialization and develop full-time and part-time inspectors. At the same time, it is necessary to highlight the professional and technical characteristics of drug inspection, reflect the "high-precision" technical level of drugs, and build a team of professional inspectors at the national and provincial levels. In the consideration of the source of the inspectors, it is recommended that the inspectors to be hired from the third party outside the supervision system, and let local pharmaceutical vocational colleges play great roles to develop potential teams of inspectors.
General office of the cpc central committee. General office of the state council. Opinions on deepening the reform of the review and approval system and encouraging drug and medical device innovation (2018-07-16)[2017-04-18]. http://www.gov.cn/xinwen/2017-10/08/content_5230105.htm.
[2]
DENG T. Research on countermeasures of construction of the state professional inspector team of drug based on the successful experience of mayo clinic. China Licensed Pharm(�й�ִҵҩʦ), 2016,(9):33-39.
[3]
HUANG W H, TIAN S L, DONG J P, et al. Inspector training system and its enlightenment on the improvement of Chinese drug inspector training system. Chin Pharm Aff(�й�ҩ��), 2017,31(11):1276-1280.
[4]
MA Y F, LIANG Y. Discussion on existing problems of GMP inspectors in drugs. J China Prescrip Drug(�й�����ҩ), 2010,8(4):68-69.
[5]
YAN Z G, HAN F. Pharmaceutical inspector system and its enlightenment in Japan. J China National School Admin(��������ѧԺѧ��), 2018,(1):127-131,152.
2019, Vol. 54 
